`
Transparency Market Research Companion Diagnostics Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019
Published Date 2013-08-29
89 Page Report
Buy Now
Request Sample
Press Release
Companion Diagnostics Market to Hit $5.6 Billion in 2019
Transparency Market Research State Tower, 90, State Street, Suite 700. Albany, NY 12207 United States www.transparencymarketresearch.com sales@transparencymarketresearch.com
Companion Diagnostics Market
REPORT DESCRIPTION
Companion Diagnostics Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 – 2019 The global companion diagnostics market will be valued at $5.6 billion in 2019. It is expected to grow at a CAGR of 18.1% from 2013 to 2019, and was valued at $1.8 billion in 2013, according to a research report published by Transparency Market Research. The research report, titled “Companion Diagnostics Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019”, fully explores current and future possibilities in the growing segment of companion diagnostics. The report states that the companion diagnostics market for breast cancer was the dominant sector in 2012, in terms of revenue. The upcoming sector for the near future is lung cancer. The segment is growing at a CAGR of more than 20% between 2013 and 2019. The report cites reasons for growth as the discovery of lung cancer specific biomarkers, along with a myriad of relevant companion diagnostics. Browse The Market Research Report of Companion Diagnostics Market : http://www.transparencymarketresearch.com/companion-diagnostics-market.html The largest market according to region in 2012 was North America, with the E.U. in following. The report said that the factors that favored the market’s growth were positive healthcare policies, a growing consumer base, increasing disposable incomes, improvements in healthcare systems, and increased awareness. The acceptance of modern medicine into mainstream sectors in the U.S. and the E.U. are the prime reasons for the growth of this market. The Asia-Pacific region and the Rest of the World regions are set to show considerable growth by the year 2019. The report cites untapped potential, increasing disposable incomes, and an improving healthcare infrastructure.
The report explains that companion diagnostics are tests which assist physicians while making decisions regarding the most efficient treatment methods, depending on responses by the patient over ongoing treatment.
Transparency Market Research
2
Companion Diagnostics Market
Get Free Sample Report : http://www.transparencymarketresearch.com/sample/sample.php?flag=s&rep_id=387 Key restraints as explained by the report include regulatory restrictions, commercialization of companion diagnostics, heavy procedure costs, long phases of approval, and lack of reach towards the low income countries. Key companies in the companion diagnostics market include Quagen N.V., Abbott Laboratories, Life Technologies, Genomic Health, Inc., GE Healthcare Ltd., Roche Holdings AG, Agilent Technologies, Inc., and Agendia N.V. The report provides exhaustive details on the companion diagnostics market by segmenting it according to indications and geography. By indications, the market is classified into breast cancer, lung cancer, melanoma, gastric cancer, colorectal cancer, and others such as HIV and thalassemia. According to geography, the reports details North America, Europe, Asia-Pacific, and Rest of the World. Browse Press Release of Companion Diagnostics Market : http://www.transparencymarketresearch.com/pressrelease/companion-diagnosticsmarket.htm
TABLE OF CONTENT
Chapter 1 Introduction 1.1 Report Description 1.2 Market Segmentation 1.3 Research Methodology 1.4 List of Abbreviations
Transparency Market Research
3
Companion Diagnostics Market
Chapter 2 Executive Summary
Chapter 3 Market Overview 3.1 Introduction 3.2 Market Drivers 3.2.1 Regulatory changes: The need for development of CDx along with targeted therapies 3.2.2 Increasing demand as well as developmental efforts towards personalized medicine 3.2.3 The pharmacoeconomic advantage: Reduced drug development costs 3.2.4 Increasing cancer incidence worldwide 3.2.5 Impact Analysis of Market Drivers 3.3 Market Restraints 3.3.1 Effect of influence of advocacy groups and clinical societies 3.3.2 Prolonged developmental and approval phases 3.3.3 Reimbursement scenario 3.3.4 Impact Analysis of Market Restraints 3.4 Market Opportunity 3.4.1 Expansion into newer indication areas 3.5 Porter’s Five Forces Analysis: Global Companion Diagnostics Market 3.5.1 Bargaining Power of Suppliers 3.5.2 Bargaining Power of Buyers
Transparency Market Research
4
Companion Diagnostics Market
3.5.3 Threat of Substitutes 3.5.4 Threat of New Entrants 3.5.5 Competitive Rivalry 3.6 Market Attractiveness Analysis: Global Companion Diagnostics Market, by Geography, 2012
Chapter 4 Companion Diagnostics Market, by Indication, 2011 - 2019 (USD Million) 4.1 Introduction 4.1.1 Comparative Analysis: Global Companion Diagnostics Market, by Indication, 2012 & 2019 (Value %) 4.1.2 Breast Cancer 4.1.2.1 Global Breast Cancer Companion Diagnostics Market, Size and Forecast, 2011 - 2019 (USD Million) 4.1.3 Lung Cancer 4.1.3.1 Global Lung Cancer Companion Diagnostics Market, Size and Forecast, 2011 2019 (USD Million) 4.1.4 Colorectal Cancer 4.1.4.1 Global Colorectal Cancer Companion Diagnostics Market, Size and Forecast, 2011 - 2019 (USD Million) 4.1.5 Gastric Cancer 4.1.5.1 Global Gastric Cancer Companion Diagnostics Market, Size and Forecast, 2011 - 2019 (USD Million) 4.1.6 Melanoma
Transparency Market Research
5
Companion Diagnostics Market
4.1.6.1 Global Melanoma Companion Diagnostics Market, Size and Forecast, 2011 2019 (USD Million) 4.1.7 Others (HIV, Thalassemia) 4.1.7.1 Global Other Companion Diagnostics Market, Size and Forecast, 2011 - 2019 (USD Million)
Chapter 5 Companion Diagnostics Market, by Geography, 2011 - 2019 (USD Million) 5.1 Overview 5.1.1 Comparative Analysis: Global Companion Diagnostics Market by Geography, 2012 & 2019 (Value %) 5.2 North America 5.2.1 North America Companion Diagnostics Market, Size and Forecast, 2011 - 2019 (USD Million) 5.3 Europe 5.3.1 Europe Companion Diagnostics Market, Size and Forecast, 2011 - 2019 (USD Million) 5.4 Asia-Pacific 5.4.1 Asia-Pacific Companion Diagnostics Market, Size and Forecast, 2011 - 2019 (USD Million) 5.5 Rest of the World (RoW) 5.5.1 RoW Companion Diagnostics Market, Size and Forecast 2011 - 2019 (USD Million)
Transparency Market Research
6
Companion Diagnostics Market
Chapter 6 Competitive Landscape 6.1 Market Share by Key Players, 2012 (%)
Chapter 7 Recommendations 7.1 Adoption of newer business models enabling co-developing companion diagnostics 7.2 Focus on research-intense investments
Chapter 8 Company Profiles 8.1 Abbott Laboratories 8.1.1 Company Overview 8.1.2 Financial Overview 8.1.3 Product Portfolio 8.1.4 Business Strategies 8.1.5 Recent Developments 8.1.5.1 FDA Approval 8.2 Agendia N.V. 8.2.1 Company Overview 8.2.2 Product Portfolio 8.2.3 Business Strategies 8.2.4 Recent Developments
Transparency Market Research
7
Companion Diagnostics Market
8.3 Agilent Technologies, Inc. 8.3.1 Company Overview 8.3.2 Financial Overview 8.3.3 Product Portfolio 8.3.4 Business Strategies 8.3.5 Recent Developments 8.4 BioGenex Laboratories Inc. 8.4.1 Company Overview 8.4.2 Product Portfolio 8.4.3 Business Strategies 8.4.4 Recent Developments 8.5 bioMĂŠrieux SA 8.5.1 Company Overview 8.5.2 Financial Overview 8.5.3 Product Portfolio 8.5.4 Business Strategies 8.5.5 Recent Developments 8.6 GE Healthcare Ltd. 8.6.1 Company Overview 8.6.2 Financial Overview
Transparency Market Research
8
Companion Diagnostics Market
8.6.3 Product Portfolio 8.6.4 Business Strategies 8.6.5 Recent Developments 8.7 Genomic Health, Inc. 8.7.1 Company Overview 8.7.2 Financial Overview 8.7.3 Product Portfolio 8.7.4 Business Strategies 8.7.5 Recent Developments 8.8 Life Technologies Corporation 8.8.1 Company Overview 8.8.2 Financial Overview 8.8.3 Product Portfolio 8.8.4 Business Strategies 8.8.5 Recent Developments 8.9 Qiagen N.V. 8.9.1 Company Overview 8.9.2 Financial Overview 8.9.3 Product Portfolio 8.9.4 Business Strategies
Transparency Market Research
9
Companion Diagnostics Market
8.9.5 Recent Developments 8.10 Resonance Health Analysis Services Pty Ltd. 8.10.1 Company Overview 8.10.2 Product Portfolio 8.10.3 Business Strategies 8.10.4 Recent Developments 8.11 Roche Holdings AG 8.11.1 Company Overview 8.11.2 Financial Overview 8.11.3 Product Portfolio 8.11.4 Business Strategies 8.11.5 Recent Developments 8.12 Siemens Healthcare 8.12.1 Company Overview 8.12.2 Financial Overview 8.12.3 Product Portfolio 8.12.4 Business Strategies 8.12.5 Recent Developments List of Figures
Transparency Market Research
10
Companion Diagnostics Market
FIG. 1 Companion Diagnostics Market Segmentation FIG. 2 Global Companion Diagnostics Market, by Indication, 2012 (USD Million) FIG. 3 Porter’s Five Forces Analysis: Global Companion Diagnostics Market FIG. 4 Market Attractiveness Analysis: Global Companion Diagnostics Market, by Geography, 2012 FIG. 5 Comparative Analysis: Global Companion Diagnostics Market, by Indication, 2012 & 2019 (Value %) FIG. 6 Global Breast Cancer Companion Diagnostics Market, Size and Forecast, 2011 - 2019 (USD Million) FIG. 7 Global Lung Cancer Companion Diagnostics Market, Size and Forecast, 2011 - 2019 (USD Million) FIG. 8 Global Colorectal Cancer Companion Diagnostics Market, Size and Forecast, 2011 - 2019 (USD Million) FIG. 9 Global Gastric Cancer Companion Diagnostics Market, Size and Forecast, 2011 - 2019 (USD Million) FIG. 10 Global Melanoma Companion Diagnostics Market, Size and Forecast, 2011 - 2019 (USD Million) FIG. 11 Global Other Companion Diagnostics Market, Size and Forecast, 2011 - 2019 (USD Million) FIG. 12 Comparative Analysis: Global Companion Diagnostics Market, by Geography, 2012 & 2019 (Value %) FIG. 13 North America Companion Diagnostics Market, Size and Forecast, 2011 – 2019 (USD Million)
Transparency Market Research
11
Companion Diagnostics Market
FIG. 14 Europe Companion Diagnostics Market, Size and Forecast, 2011 – 2019 (USD Million) FIG. 15 Asia-Pacific Companion Diagnostics Market, Size and Forecast, 2011 – 2019 (USD Million) FIG. 16 RoW Companion Diagnostics Market, Size and Forecast, 2011 - 2019 (USD Million) FIG. 17 Market Share Analysis: Global Companion Diagnostics Market, 2012 (%) FIG. 18 Annual Revenues: Abbott Laboratories, 2010 – 2012 (USD Million) FIG. 19 Annual Revenue: Agilent Technologies, Inc., 2010 – 2012 (USD Million) FIG. 20 Annual Revenues: bioMérieux SA, 2010 – 2012 (USD Million) FIG. 21 Annual Revenue: GE Healthcare Ltd., 2010 – 2012 (USD Million) FIG. 22 Annual Revenues: Genomic Health Inc., 2010 – 2012 (USD Million) FIG. 23 Annual Revenues: Life Technologies Corporation, 2010 – 2012 (USD Million) FIG. 24 Annual Sales: Qiagen N.V., 2010 – 2012 (USD Million) FIG. 25 Annual Revenues: Roche Holdings AG, 2010 – 2012 (USD Million) (1 CHF = 1.09 USD) FIG. 26 Annual Revenues: Siemens Healthcare, 2010 – 2012 (USD Million) List of Tables
TABLE 1 List of Abbreviations TABLE 2 Market Snapshot: Global Companion Diagnostics Market TABLE 3 Cancer Incidence, by Type, 2008 and 2015 (Million) TABLE 4 Impact Analysis of Market Drivers
Transparency Market Research
12
Companion Diagnostics Market
TABLE 5 Impact Analysis of Market Restraints TABLE 6 Companion Diagnostics Required or Recommended by the U.S. FDA TABLE 7 Global Companion Diagnostics Market, by Indication, 2011 - 2019 (USD Million) TABLE 8 Breast Cancer Companion Diagnostics (CDx), Manufacturers and Target Drugs TABLE 9 Lung Cancer Companion Diagnostics (CDx), Manufacturers and Target Drugs TABLE 10 Colorectal Cancer Companion Diagnostics (CDx), Manufacturers and Target Drugs TABLE 11 Gastric Cancer Companion Diagnostics (CDx), Manufacturers and Target Drugs TABLE 12 Melanoma Companion Diagnostics (CDx), Manufacturers and Target Drugs TABLE 13 Other Companion Diagnostics (CDx), Indications and Manufacturers TABLE 14 Global Companion Diagnostics Market, by Geography, Size and Forecast, 2011 - 2019 (USD Million)
Browse All Biotechnology Market Research Reports @ http://www.transparencymarketresearch.com/biotechnology-market-reports18.html About Us
Transparency Market Research is a market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forwardlooking insight for thousands of decision makers. We are privileged with highly experienced team of Analysts, Researchers and Consultants, who use proprietary data sources and various tools and techniques to gather, and analyze information. Our
Transparency Market Research
13
Companion Diagnostics Market
business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.
Contact Transparency Market Research 90 State Street, Suite 700, Albany NY - 12207 United States Tel: +1-518-618-1030 USA - Canada Toll Free 866-552-3453 Email: sales@transparencymarketresearch.com Website: http://www.transparencymarketresearch.com/
Transparency Market Research
14